San-Laung Chow

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Biokey, Inc., Fisons Ltd., Synchroneuron, Inc.. Active years: 1989-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: San-Laung Chow. Retrieved from https://idiyas.com/inventor/san-laung-chow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 57.1

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 131(Granted Patents)

Location History:

Perinton, NY (US) (1989 - 1990)
San Jose, CA (US) (2006 - 2016)

Company Filing History:

Years Active: 1989-2016

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9427420 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-30),

2. 8617601 - Methods and formulations for making pharmaceutical compositions containing bupropion (2013-12-31),

3. 8586085 - Methods and formulations for making pharmaceutical compositions containing bupropion (2013-11-19),

4. 7063862 - Pharmaceutical composition and method for treating (2006-06-20),

5. 4959219 - Coating barriers comprising ethyl cellulose (1990-09-25),

6. 4859462 - Polymer-treated ion exchange resins (1989-08-22),

7. 4859461 - Coatable ion exchange resins (1989-08-22),

Title: The Innovative Contributions of San-Laung Chow

Introduction

San-Laung Chow is a notable inventor based in San Jose, California, recognized for his significant contributions to pharmaceutical formulations. With a total of seven patents to his name, Chow has made strides in the development of medications that address critical health issues.

Latest Patents

Chow's latest patents include innovative formulations and methods related to acamprosate and bupropion. One of his patents focuses on acamprosate formulations, detailing methods of use and combinations with other medications, such as neuroleptic and antidepressant drugs. Another patent provides methods for creating pharmaceutical compositions containing bupropion, emphasizing the preparation of oral drug compositions, including extended-release dosage forms. These formulations aim to enhance treatment options for conditions like depression and smoking cessation.

Career Highlights

Throughout his career, Chow has worked with reputable companies, including Fisons Ltd. and Biokey, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Chow has collaborated with notable professionals in the field, including David N. Wong and Yegnaswami Raghunathan. These partnerships have likely enriched his research and development efforts.

Conclusion

San-Laung Chow's work in pharmaceutical innovations showcases his dedication to improving health outcomes through effective medication formulations. His contributions continue to influence the field of pharmaceuticals significantly.

Profile summary based on public USPTO records.